[Rapporto di ricerca] Il mercato dei test genetici prenatali e neonatali è stato valutato a 4.034,4 milioni di dollari nel 2018 e si prevede che raggiungerà 11.204,7 milioni di dollari nel 2027; si prevede che crescerà a un CAGR del 12,2% dal 2019 al 2027.
I test genetici prenatali vengono eseguiti durante la gravidanza per la diagnosi di malattie o l'individuazione di specifiche malattie anomalie genetiche prima delle 8-10 settimane di gestazione e aiuta anche a determinare il sesso del feto. La maggior parte dei test genetici prenatali utilizza un campione di sangue della madre per condurre vari screening. I metodi diagnostici sono più efficaci, accurati e rappresentano un'opzione preferita per il rilevamento di anomalie cromosomiche rispetto ai metodi di screening. La crescita del mercato globale dei test genetici prenatali e neonatali è attribuita all’aumento della prevalenza delle malattie genetiche tra i neonati, al sostegno del governo nella promozione dell’uso dei test prenatali e neonatali e all’aumento del tasso di natalità. Tuttavia, il rischio associato ai test genetici prenatali è il principale fattore che ostacola la crescita del mercato.
Si prevede che il mercato globale dei test genetici prenatali e neonatali assisterà a una crescita sostanziale dopo la pandemia. . Il COVID-19 ha colpito le economie e le industrie di vari paesi a causa di blocchi, divieti di viaggio e chiusure di attività commerciali. La crisi del Covid-19 ha sovraccaricato i sistemi sanitari pubblici in molti paesi e ha evidenziato la forte necessità di investimenti sostenibili nei sistemi sanitari. Con il progredire della pandemia di COVID-19, si prevede che il settore sanitario registrerà un calo della crescita. Il segmento delle scienze della vita prospera grazie alla crescente domanda di prodotti diagnostici in vitro e alle crescenti attività di ricerca e sviluppo in tutto il mondo. Tuttavia, il segmento delle tecnologie mediche e dell'imaging sta registrando un calo delle vendite a causa del minor numero di interventi chirurgici eseguiti e del ritardo o del prolungamento dell'approvvigionamento delle apparecchiature. Inoltre, si prevede che le consultazioni virtuali da parte degli operatori sanitari diventeranno il modello tradizionale di erogazione delle cure post-pandemia. Con la telemedicina che sta trasformando l’erogazione delle cure, la sanità digitale continuerà a prosperare nei prossimi anni. Inoltre, si prevede che l’interruzione delle sperimentazioni cliniche e il conseguente ritardo nel lancio dei farmaci apriranno la strada a sperimentazioni interamente virtuali in futuro. Si prevede che nuove tecnologie come l’mRNA emergano e spostino l’industria farmaceutica e si prevede che il mercato sarà testimone di una maggiore integrazione verticale e di joint venture nei prossimi anni.
Regioni redditizie per il mercato globale dei test genetici prenatali e neonatali
Approfondimenti sul mercato
L'elevata prevalenza di malattie genetiche nei neonati guiderà la crescita del mercato globale dei test genetici prenatali e neonatali
Diversi tipi di malattie genetiche colpiscono i feti nel grembo materno. Il modo in cui queste malattie genetiche vengono ereditate aiuta a determinare il rischio che comportano per la gravidanza, nonché il rischio di recidiva. Il rischio di contrarre malattie genetiche nei bambini è elevato nei casi in cui i genitori hanno un altro figlio con una malattia genetica, storia familiare di una malattia genetica o se uno dei genitori ha un'anomalia cromosomica. Esiste una significativa prevalenza di malattie genetiche tra i neonati. Inoltre, queste malattie sono anche responsabili della mortalità infantile in tutto il mondo. Ad esempio, secondo l’Organizzazione Mondiale della Sanità del 2016, circa 7,9 milioni di bambini in tutto il mondo nascono con difetti genetici. Inoltre, secondo i Centri per il controllo e la prevenzione delle malattie (CDC), i difetti alla nascita colpiscono 1 bambino su 33 nato negli Stati Uniti. D'altra parte, anomalie cromosomiche come la sindrome di Down colpiscono 1 bambino su 691 nati negli Stati Uniti, secondo i dati del CDC nel 2017.
D'altra parte , un sondaggio condotto dalla John Hopkins University nel 2015 afferma che circa il 20-30% delle morti infantili sono il risultato di malattie genetiche. Alcune delle principali malattie metaboliche determinate geneticamente comprendono l'anemia falciforme, la fenilchetonuria, la talassemia e altre. La sindrome di Down è il disturbo cromosomico più comune che colpisce circa 6000 bambini negli Stati Uniti, secondo le statistiche del CDC. Inoltre, secondo un rapporto pubblicato da Stanford's Children Health nel 2018, l'anemia falciforme si verifica in quasi 1 su 365 nati afroamericani neri. Pertanto, l'elevata prevalenza di malattie genetiche tra i neonati spiega la crescente domanda di test genetici prenatali e neonatali, contribuendo così alla crescita del mercato.
Approfondimenti basati sul prodotto
Mercato globale dei test genetici prenatali e neonatali, per prodotto– 2018 e 2027
Approfondimenti basati sull'indicazione della malattia
In termini di indicazione della malattia, il sistema prenatale e Il mercato dei test genetici neonatali è segmentato in fibrosi cistica, anemia falciforme, sindrome di Down, fenilchetonuria e altre malattie. Nel 2018, il segmento della sindrome di Down deteneva la quota maggiore del mercato. Tuttavia, si prevede che il segmento della fibrosi cistica registrerà il CAGR più elevato durante il periodo di previsione.
Approfondimenti basati sugli utenti finali
In termini di fine utente, il mercato globale dei test genetici prenatali e neonatali è segmentato in ospedali & cliniche, centri diagnostici e altri utenti finali. Il segmento degli ospedali e delle cliniche ha detenuto la quota maggiore del mercato nel 2018. Tuttavia, si stima che il segmento della diagnostica crescerà al ritmo più rapido durante il periodo di previsione.
Strategico Approfondimenti
Gli attori globali del mercato dei test genetici prenatali e neonatali stanno adottando lanci di prodotti, partnership e acquisizioni per soddisfare le mutevoli richieste dei clienti in tutto il mondo, il che consente loro anche di mantenere il proprio marchio a livello globale.
Mercato globale dei test genetici prenatali e neonatali - per prodotto
- Diagnostica
- Spettrofotometro
- Reazione a catena della polimerasi
- Fluorescenza in- ibridazione situ
- Ibridazione genomica comparativa con array
- Screening
- Screening del siero materno
- Prelievo cronico di villi
- Amniocentesi
- Test prenatali non invasivi
Mercato globale dei test genetici prenatali e neonatali - per indicazione della malattia
- Fibrosi cistica
- Anemia falciforme
- Sindrome di Down
- Fenilchetonuria
- Altro Malattie
Mercato globale dei test genetici prenatali e neonatali - per utente finale
- Ospedali e ospedali Cliniche
- Centri diagnostici
- Altri utenti finali
Mercato globale dei test genetici prenatali e neonatali: per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'APAC
- Medio Oriente e Asia Africa (MEA)
- Sudafrica
- Arabia Saudita
- EAU
- Resto del MEA
- America del Sud e America Centrale (SCAM)
- Brasile
- Argentina
- Resto dello SCAM
< /ul> - Abbott
- Quest Diagnostics Incorporated
- Ravgen
- Bio-Rad Laboratories, Inc.,
- Illumina, Inc.
- F. Hoffmann La-Roche Ltd.
- Qiagen
- Berry Gene
- PerkinElmer, Inc.
- Natera, Inc. < li>Laboratory Corporation of America Holdings (Sequenom)
Profili aziendali
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
- Abbott
- Quest Diagnostics Incorporated
- Ravgen
- Bio-Rad Laboratories, Inc.
- Illumina, Inc.
- F. Hoffmann La-Roche Ltd.
- Qiagen
- Berry Gene
- PerkinElmer, Inc.
- Natera, Inc.
- Laboratory Corporation of America Holdings (Sequenom)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Jul 2019
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jul 2019
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2019
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Jul 2019
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Jul 2019
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Jul 2019
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Jul 2019
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)